000 01356 a2200385 4500
005 20250517233906.0
264 0 _c20190213
008 201902s 0 0 eng d
022 _a1879-0712
024 7 _a10.1016/j.ejphar.2018.08.026
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSherkawy, Marwa M
245 0 0 _aFluoxetine protects against OVA induced bronchial asthma and depression in rats.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cOct 2018
300 _a25-32 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAsthma
_xphysiopathology
650 0 4 _aBrain-Derived Neurotrophic Factor
_xanalysis
650 0 4 _aDepression
_xprevention & control
650 0 4 _aDexamethasone
_xtherapeutic use
650 0 4 _aFluoxetine
_xtherapeutic use
650 0 4 _aImmunoglobulin E
_xblood
650 0 4 _aInterleukin-4
_xanalysis
650 0 4 _aMale
650 0 4 _aOvalbumin
_ximmunology
650 0 4 _aOxidative Stress
650 0 4 _aPeak Expiratory Flow Rate
_xdrug effects
650 0 4 _aRats
700 1 _aAbo-Youssef, Amira M
700 1 _aSalama, Abeer A A
700 1 _aIsmaiel, Ismaiel E
773 0 _tEuropean journal of pharmacology
_gvol. 837
_gp. 25-32
856 4 0 _uhttps://doi.org/10.1016/j.ejphar.2018.08.026
_zAvailable from publisher's website
999 _c28766544
_d28766544